Capital Markets Bulletin

Today’s Issue

02
Life Sciences · Drug Delivery · Patents

Lexaria reports animal-study results for CBD formulation

The company says one new DehydraTECH-CBD formulation produced a 566% improvement in brain absorption in an animal study, and has filed three related patent applications.